Next-Generation Assessment of Human Epithelial Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay

Establishing ERBB2 [human epidermal growth factor receptor 2 (HER2)] amplification status in breast and gastric carcinomas is essential to treatment selection. Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) constitute the current standard for assessment. With further advanc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Mol Diagn
Main Authors: Ross, Dara S., Zehir, Ahmet, Cheng, Donavan T., Benayed, Ryma, Nafa, Khedoudja, Hechtman, Jaclyn F., Janjigian, Yelena Y., Weigelt, Britta, Razavi, Pedram, Hyman, David M., Baselga, José, Berger, Michael F., Ladanyi, Marc, Arcila, Maria E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2017
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5397722/
https://ncbi.nlm.nih.gov/pubmed/28027945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2016.09.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados